Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Maprotiline hydrochloride 10 mg oral tablet |
Is a |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 25mg tablet (substance) |
Is a |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 50 mg oral tablet |
Is a |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 75 mg oral tablet |
Is a |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 25mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Maprotiline hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 25mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 25mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 75 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 50 mg oral tablet |
Has precise active ingredient |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 10 mg oral tablet |
Has precise active ingredient |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 25mg tablet (substance) |
Has precise active ingredient |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Maprotiline hydrochloride 75 mg oral tablet |
Has precise active ingredient |
True |
Maprotiline hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |